Dietary Patterns: Mediterranean, DASH, Plant-Based & Beyond

Citation model. Claims grounded in AllNutrition's trust-scored library carry an inline bracketed reference [n] linking to the References section, which lists each source's evidence level and AllNutrition trust score (0–1). Where an AllNutrition query returned an overall evidence_strength and consensus_level, those labels are surfaced in the Evidence Review so readers can calibrate confidence. Only sources actually returned by the tool are cited; no trust scores are invented. Mechanistic detail specific to a single disease (atherosclerosis, hypertension, diabetes, neurodegeneration) is covered in depth in the disease-specific modules of this course; this module cross-references rather than duplicates that material.

---

1. Introduction

Module 1 established why nutritional epidemiology increasingly studies whole dietary patterns rather than isolated nutrients: diet is compositional and relational, nutrients act synergistically, and substitution effects make single-nutrient claims ambiguous. This module operationalizes that principle. Across cardiology, endocrinology, oncology, and neurology, a small number of named dietary patterns — Mediterranean, DASH, plant-based/vegetarian/vegan, the EAT-Lancet "planetary health" diet, Nordic, MIND, and low-carbohydrate/ketogenic — recur as the evidence-backed vocabulary clinicians use with patients. Each pattern differs in its specific food list, yet they converge repeatedly on similar downstream biology: lower LDL/apoB burden, reduced blood pressure, improved insulin sensitivity, reduced systemic inflammation, and favorable shifts in the gut microbiome [1][43]. Understanding where these patterns converge, where they diverge, and how strong the evidence is for each claimed benefit is essential for translating "eat a healthy diet" into a specific, patient-appropriate, evidence-graded recommendation.

This module also confronts a methodological reality: most dietary-pattern evidence is observational, indices used to score adherence vary across studies (there is no single "Mediterranean diet"), and results for the same pattern sometimes diverge by outcome, population, and even by adherence-scoring method [4][19]. The clinician's task is not to declare one pattern universally superior but to match pattern to patient — considering the target outcome, comorbidities, culture, cost, and sustainability.

2. Learning Objectives

By the end of this module, the learner will be able to:

1. Explain the shared biological mechanisms (lipid/apoB modulation, blood pressure, insulin sensitivity, inflammation, gut microbiome) through which structurally different healthy dietary patterns converge on similar cardiometabolic benefit.
2. Summarize the trial and cohort evidence for the Mediterranean diet across cardiovascular disease, type 2 diabetes, mortality, and cognition, including the PREDIMED trial and its re-analysis.
3. Describe the evidence for DASH on blood pressure and cardiovascular outcomes, including where its effect on hard endpoints (mortality, heart failure) is weaker or less consistent than its effect on blood pressure.
4. Discuss vegetarian/vegan and other plant-based patterns' associations with cardiovascular disease, cancer, and mortality, alongside the nutrient-adequacy risks (B12, iron, omega-3, calcium, iodine, zinc) that must be actively managed.
5. Compare the EAT-Lancet planetary health diet, Nordic diet, and MIND diet to Mediterranean/DASH, and describe the evidence base and limits for low-carbohydrate/ketogenic patterns and ultra-processed-food harms.
6. Apply diet-quality indices (HEI, AHEI, DASH score, Mediterranean score) to interpret mortality-risk literature, and counsel patients on adherence, cost, equity, and cultural adaptation.

3. Scientific Foundations

3.1 Why patterns, not nutrients

Chronic disease is increasingly understood as driven by a small number of "central hubs" — insulin resistance/hyperinsulinemia, systemic inflammation, and dyslipidemia (particularly apoB particle burden, covered mechanistically in Module 10) — and food-based dietary-pattern indices predict these hubs (e.g., C-peptide, inflammatory cytokines) more consistently than single-nutrient intake [43]. Whole patterns also capture non-nutrient features that plausibly matter clinically: meal timing, food matrix effects (e.g., calcium and probiotics in fermented dairy attenuating the LDL-raising effect of dairy saturated fat), and the social/behavioral context of eating [43]. Nutritional epidemiology treats pattern-level analysis as closer to the "gold standard" than nutrient-level analysis for this reason [43].

3.2 Convergent mechanisms across "healthy" patterns

Despite different food lists, the Mediterranean, DASH, and healthy plant-based patterns repeatedly converge on the same intermediate pathways:

• Lipids/apoB. Replacing saturated fat with unsaturated fat (a common thread across Mediterranean, DASH, and healthy plant-based patterns) lowers LDL-C and apoB and is associated with an estimated ~21% reduction in cardiovascular events in feeding-trial data; the effect is attenuated or lost if saturated fat is instead replaced with refined carbohydrate [full mechanistic detail in Module 10].
• Blood pressure. DASH's high potassium, magnesium, calcium, nitrate, and fiber content promotes natriuresis, vasodilation via nitric-oxide synthesis, and reduced vascular smooth-muscle tone, independent of sodium restriction, though sodium restriction adds further benefit [full mechanistic detail in Module 11].
• Inflammation. Mediterranean-pattern polyphenols, omega-3s, and fiber-driven short-chain fatty acid production reduce CRP, IL-6, and TNF-α, and inflammatory mediation (via markers such as the neutrophil-to-platelet ratio) has been identified as a statistically significant pathway linking dietary pattern adherence to mortality risk [43][32].
• Gut microbiome. Mediterranean, DASH, and plant-forward patterns each increase microbial diversity and butyrate-producing taxa, reduce gut permeability, and lower TMAO — a pathway increasingly implicated across cardiometabolic outcomes [43].
• Glycemic/insulin pathways. Fiber-rich, minimally processed patterns lower postprandial glucose excursions and improve insulin sensitivity partly via short-chain fatty acid signaling [43][7].

This mechanistic convergence is the biological rationale for the clinical observation that several different "healthy" patterns can each independently reduce cardiometabolic risk — the shared final common pathways matter more than any single food.

3.3 Divergence and pattern-specific strengths

Network and comparative-effectiveness analyses show that no single pattern dominates on every outcome: the Mediterranean pattern shows the most consistent fasting-glucose control and the strongest mortality signal via multi-pathway anti-inflammatory action; vegan/vegetarian patterns most consistently lower LDL-C; DASH is most reliably effective for blood pressure and short-term weight loss; and ketogenic/low-carbohydrate patterns are most effective for triglyceride reduction and short-term glycemic control, with effects that often converge with other patterns by 12–24 months [21][12][18][31].

4. Clinical Relevance

Primary-care, cardiology, and endocrinology encounters routinely require a clinician to recommend a dietary pattern rather than a nutrient target. Patients ask "should I go Mediterranean, keto, or vegan?" and the evidence-based answer depends on the outcome being targeted (blood pressure vs. LDL vs. weight vs. glycemic control vs. long-term mortality), comorbidities (chronic kidney disease changes potassium/protein calculus; established CVD changes urgency), and what the patient can sustain — since even the best-evidenced pattern produces no benefit if abandoned. This module gives the clinician a framework: identify the target outcome, select the pattern(s) with the strongest evidence for that specific outcome, and then negotiate an adapted, affordable, culturally congruent version with the patient.

5. Evidence Review

Established (high confidence):

• The Mediterranean diet (with olive oil or nuts) reduces major cardiovascular events in high-risk primary prevention (PREDIMED: HR ≈0.65 intention-to-treat, HR ≈0.42 per-protocol) and this is corroborated by CORDIOPREV (HR 0.72–0.75) and multiple systematic reviews underpinning national guidelines. AllNutrition evidence_strength: strong, consensus_level: high/moderate [32][4][3][11].
• DASH significantly lowers systolic and diastolic blood pressure independent of sodium intake, with added benefit from sodium restriction; effect is larger in those with higher baseline blood pressure or BMI. evidence_strength: strong, consensus: moderate [17][24].
• Ultra-processed food intake is associated with increased all-cause mortality (~25%), cardiovascular disease (~29%), and cerebrovascular disease (~34%) in large pooled cohorts. evidence_strength (BJN 2021 SR): strong by trust/design; corroborated by independent 2026 cohort** [39][6].
• Vegan diets require proactive management of vitamin B12 (supplementation essentially mandatory), and attention to iron, omega-3 (EPA/DHA via algae), calcium, zinc, and iodine. evidence_strength: moderate, consensus: moderate, but near-universal in guideline-level sources [43][33][42].

Probable:

• Mediterranean diet adherence reduces incident type 2 diabetes in a dose-response fashion (~19–21% risk reduction at high adherence; ~8% lower risk per 2-point adherence-score increase) [5][26].
• Mediterranean and DASH/MIND-hybrid patterns are associated with slower cognitive decline and lower dementia/Alzheimer's risk, with DASH showing the strongest association with slower six-year cognitive decline in at least one longitudinal cohort. evidence_strength: strong, consensus: moderate [10].
• Vegetarian/vegan diets are associated with reduced cardiovascular disease and ischemic heart disease risk (~15–25%) and modestly reduced all-cause mortality, with the mortality benefit attenuating with advancing age. evidence_strength: moderate, consensus: moderate [27][29].
• Diet-quality indices (Alternate Mediterranean Diet score, AHEI, HEI, DASH score) each independently predict lower all-cause and cardiovascular mortality and gains in life expectancy, with the Mediterranean-pattern index showing the largest effect size in head-to-head causal-inference comparisons. evidence_strength: strong, consensus: moderate [25][23].
• Low-carbohydrate/ketogenic diets produce superior short-term (≤12 months) weight loss and glycemic control, with favorable triglyceride/HDL changes but frequently unfavorable LDL-C increases; most between-diet differences disappear by 24 months. evidence_strength: strong, consensus: moderate [12][31].

Emerging:

• The EAT-Lancet planetary health diet shows a plausible mortality and chronic-disease benefit in some cohorts (Sweden) but not others (UK, US), and adherence-index heterogeneity across studies complicates comparison; environmental benefit (GHG emissions, land use) is more consistently demonstrated than the health benefit. evidence_strength: strong for environmental outcomes, moderate/mixed for health outcomes [22][19].
• Diet-quality index integration with epigenetic aging and inflammatory-mediator pathways (CRP, neutrophil-to-platelet ratio, systemic immune-inflammation index) as mechanistic explanations for the diet–mortality link [23][32].
• "Healthful" vs. "unhealthful" plant-based diet indices (hPDI/uPDI) as a more granular tool than binary vegetarian/omnivore classification for predicting site-specific cancer and cardiovascular risk [16][14].

Controversial:

• Whether DASH meaningfully reduces cardiovascular mortality and heart-failure incidence, as opposed to intermediate risk factors — several analyses find null or attenuated hard-endpoint effects, plausibly because concurrent statin/antihypertensive therapy in modern high-risk cohorts masks the diet's independent contribution (a "surrogate endpoint paradox"). evidence_strength: moderate, consensus: mixed [34][32].
• Vegan diets and colorectal cancer: most plant-based cancer evidence shows protection, but one large pooled analysis (1.8 million participants) found a 40% higher colorectal cancer risk in vegans, tentatively attributed to lower calcium intake — a finding explicitly flagged by its authors as needing cautious interpretation given small case numbers [35].
• Whether the health benefit of the EAT-Lancet diet is independent of weight/BMI change, since at least one analysis found the diabetes-risk association was "largely influenced by BMI and waist circumference" rather than the dietary pattern per se [22].

Unsupported / overstated:

• Treating any single named "diet" as a fixed, universally-defined prescription: Mediterranean, EAT-Lancet, and plant-based scores are each operationalized by multiple non-identical indices, and comparing "the Mediterranean diet" across studies without specifying the scoring instrument risks comparing different exposures [19][4].
• Assuming vegan/vegetarian diets are automatically nutritionally adequate without fortification or supplementation planning — well-planned versions are adequate, but "well-planned" is doing real work in that sentence [42][33].

6. Practical Clinical Applications

Matching pattern to patient and target outcome:

• Primary/secondary CVD prevention, especially with elevated LDL/apoB or established atherosclerotic disease: Mediterranean diet with olive oil and/or nuts has the strongest RCT evidence base (PREDIMED, CORDIOPREV) [32][4]. See Module 10 for lipid/apoB mechanistic detail.
• Hypertension: DASH remains first-line dietary therapy, with the largest and most consistent blood-pressure effect size among patterns studied; effect is greater in patients with higher baseline BP or BMI [17][24]. See Module 11.
• Type 2 diabetes / insulin resistance: Mediterranean diet has the most consistent glycemic-control evidence among "whole pattern" approaches; low-carbohydrate and whole-food plant-based approaches can produce faster short-term HbA1c and insulin-resistance improvement but require monitoring for medication (especially insulin/sulfonylurea) adjustment to avoid hypoglycemia [7][12][40].
• Dyslipidemia (LDL-driven): vegan/vegetarian patterns show the largest LDL-C reductions among patterns compared head-to-head; ketogenic/very-low-carbohydrate patterns often raise LDL-C and should be used cautiously, if at all, in patients at high atherosclerotic risk [21][40].
• Cognitive protection in older adults: Mediterranean and DASH (and their MIND hybrid) are the best-evidenced patterns; benefit may be amplified in APOE4 carriers [10].
• Weight loss: DASH and ketogenic/low-carbohydrate patterns show the largest short-term (≤12 month) weight-loss effect sizes; sustainability at 24 months is the limiting factor for all patterns, including keto [21][12][31].
• Vegan/vegetarian patients (by preference, culture, or ethics): actively screen and manage B12 (essentially always supplement), iron (pair with vitamin C, consider higher intake target), omega-3 (algae-derived EPA/DHA supplement), calcium (fortified foods, low-oxalate greens), iodine (iodized salt or supplement, especially pregnancy/lactation), and zinc (soaking/sprouting/fermentation to reduce phytate) [43][33][42].
• Chronic kidney disease: DASH's high potassium/phosphorus content requires individualization; benefit of DASH-pattern adherence on mortality is less certain in CKD than in the general population [34][17].
• When not to prescribe a restrictive pattern: avoid strict ketogenic diets in patients at high cardiovascular risk without close lipid monitoring; avoid unsupplemented vegan diets in pregnancy, lactation, infancy, and childhood without professional guidance [42][22].
• Cost and equity: healthier dietary patterns cost more at the point of purchase in most studied settings (Belgium: 7–15% more; MedDiet daily cost €3.3–14.4 depending on food choices), though they are cost-effective or cost-saving over the long term via reduced healthcare utilization; a whole-food plant-based approach can in some settings be cheaper than a standard baseline diet [2][8][37]. Neighborhood food environment materially affects achievable adherence (57% vs. 68% simulated adherence in lower- vs. higher-income Los Angeles neighborhoods), and reducing the price of target foods measurably raises adherence in lower-income settings [41].
• Cultural adaptation: direct transplantation of a "Mediterranean diet" prescription onto non-Mediterranean populations (e.g., South Asia) is not straightforward — culturally adapted approaches that preserve the underlying nutritional principles (plant-forward, unsaturated fat, legumes, whole grains) while substituting traditional, accessible foods perform better than literal food-list transplantation [38].

7. Clinical Pearls

• No dietary pattern wins on every outcome — match the pattern to the specific target (BP → DASH; LDL/apoB and mortality → Mediterranean; rapid weight/glycemic response → low-carb, with monitoring).
• "The Mediterranean diet" in the literature is not one diet — adherence indices vary, so ask what score a study used before comparing results across trials.
• DASH's blood-pressure effect is one of the most robust findings in all of nutrition science; its effect on hard cardiovascular mortality endpoints is comparatively weaker and possibly masked by concurrent pharmacotherapy in modern cohorts.
• A vegan diet without B12 supplementation is not a nutritionally complete diet — treat B12 supplementation as non-negotiable, not optional.
• Diet cost is a real, quantifiable barrier (7–15% more expensive), not just an excuse — legumes, frozen produce, and traditional whole-food staples are the most reliable low-cost path to a Mediterranean/DASH-quality diet.
• Low-carbohydrate/ketogenic benefits on weight and glycemia are real but tend to converge with other patterns by 12–24 months as adherence drifts — set expectations accordingly.
• Ultra-processed food intake predicts worse outcomes even after adjusting for overall diet quality — "eat more vegetables" and "eat less ultra-processed food" are not the same instruction (see Module 29).

8. Common Misconceptions

• "There is one correct Mediterranean/plant-based diet." Multiple non-identical adherence indices exist; results depend on which is used, and heterogeneity across indices is an acknowledged limitation of the EAT-Lancet literature specifically [19].
• "A vegan diet is automatically heart-healthy and complete." It requires deliberate planning around B12, iron, omega-3, calcium, iodine, and zinc; unplanned versions carry real deficiency risk [43][33].
• "Keto and low-carb are equivalent to Mediterranean/DASH for long-term cardiovascular protection." Short-term metabolic benefits are real, but LDL-C often rises, and comparative long-term hard-outcome data remain far thinner than for Mediterranean and DASH [12][31].
• "DASH's blood-pressure benefit implies an equally strong mortality benefit." Evidence for hard cardiovascular mortality and heart-failure endpoints is more mixed than for blood pressure itself [34].
• "Healthy diets are unaffordable for low-income patients, full stop." Cost is a real barrier at market prices, but whole-food, legume-forward versions of DASH/Mediterranean-quality eating can be cost-neutral or cost-saving compared to a typical baseline diet [37][8].

9. Summary

Dietary-pattern research operationalizes the paradigm established in Module 1: because diet is compositional, relational, and synergistic, whole patterns predict chronic-disease risk better than single nutrients. The Mediterranean diet has the strongest and most consistent trial evidence for cardiovascular events, type 2 diabetes prevention, and cognitive protection; DASH has the most robust blood-pressure evidence but a weaker and more contested link to hard cardiovascular mortality; vegetarian/vegan and other plant-based patterns reduce cardiovascular and probably cancer risk but require active nutrient-adequacy management; the EAT-Lancet planetary health diet optimizes environmental outcomes with a less consistent health-outcome signal; low-carbohydrate/ketogenic patterns offer fast short-term metabolic gains that often converge with other patterns over time and carry an LDL-C caveat; and ultra-processed food intake independently predicts worse outcomes regardless of the "healthy" pattern superimposed on top of it. Diet-quality indices (HEI, AHEI, Mediterranean/DASH scores) consistently translate pattern adherence into measurable mortality and life-expectancy benefit, with inflammatory-pathway mediation as an emerging mechanistic explanation. Clinically, the task is not to declare a single winning diet but to match pattern to patient — target outcome, comorbidity, culture, and cost all matter — and to actively support adherence, since even the best-evidenced pattern only works if sustained.

10. References

Ordered by evidence strength / trust score. Evidence level and AllNutrition trust score (0–1) as returned by the tool.

1. A perspective on vegetarian dietary patterns and risk of metabolic syndrome. British Journal of Nutrition (2014). Review — trust 0.90.
2. What Europe should (not) learn from the new Dietary Guidelines for Americans. Acta Clinica Belgica (2026). Review — trust 0.90.
3. Efficacy of Mediterranean diet for the prevention of cardiovascular disease in patients (Italian National Guidelines "La Dieta Mediterranea"). Nutrition (2025). Systematic review — trust 0.883.
4. Mediterranean diet versus low-fat diet on cardiovascular disease (CVD) risk factors and outcomes: A systematic review of RCTs. Medicine (2026). Systematic review — trust 0.875.
5. Adherence to Mediterranean Diet and Risk of Type 2 Diabetes: An Updated Systematic Review and Dose–Response Meta-analysis. Advances in Nutrition (2025). Systematic review — trust 0.875.
6. Association of ultra-processed food consumption with all-cause and cause-specific mortality: population-based cohort study. Frontiers in Nutrition (2026). Observational — trust 0.863.
7. Dietary patterns and cardiovascular diseases in individuals with type 2 diabetes: a systematic review and meta-analysis of prospective observational studies. Advances in Nutrition (2026). Systematic review — trust 0.862.
8. Economic evaluations of the Mediterranean diet: a systematic review. Nutrition (2026). Systematic review — trust 0.86.
9. Network meta-analysis of the effects of different dietary patterns on patients with metabolic syndrome. Frontiers in Nutrition (2025). Systematic review — trust 0.86.
10. Efficacy of Mediterranean diet for the prevention of neurological diseases (Italian National Guidelines). Nutrition (2025). Systematic review — trust 0.86.
11. Effectiveness of Mediterranean diet for the primary prevention of cardiovascular diseases (Italian National Guidelines). Nutrition (2025). Systematic review — trust 0.857.
12. Carbohydrate-restricted diet types and macronutrient replacements for metabolic health in adults: A meta-analysis of randomized trials. Clinical Nutrition (2025). Systematic review — trust 0.857.
13. Remote dietitian counseling with short-term meal delivery improves DASH diet adherence and lowers blood pressure in veterans with hypertension and obesity. American Heart Journal (2026). RCT — trust 0.853.
14. Healthy and unhealthy plant-based diets and the risk of cardiovascular diseases: The Rotterdam study and updated meta-analysis. Progress in Cardiovascular Diseases (2024). Systematic review — trust 0.852.
15. Updating the Mediterranean Diet Pyramid towards Sustainability: Focus on Environmental Concerns. International Journal of Environmental Research and Public Health (2020). Review — trust 0.85.
16. Healthful and unhealthful plant-based diets and site-specific cancer risk: a systematic review and meta-analysis of observational studies. European Journal of Nutrition (2026). Systematic review — trust 0.842.
17. The effect of DASH diet on components of metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Nutrition (2026). Systematic review — trust 0.842.
18. Metabolic, adherence, and sustainability outcomes of plant-based low-carbohydrate and ketogenic diets: A systematic review of clinical evidence. Nutrition (2026). Systematic review — trust 0.842.
19. Association between EAT-Lancet diet adherence and cancer incidence/mortality: a systematic review and meta-analysis. Frontiers in Oncology (2026). Systematic review — trust 0.838.
20. Immunometabolic Organ Crosstalk in Heart Failure with Preserved Ejection Fraction: The Role of Dietary Patterns in Obesity-Related Inflammation. Nutrients (2026). Review — trust 0.833.
21. Comparative effect of dietary patterns on selected cardiovascular risk factors: A network study. Scientific Reports (2025). Systematic review — trust 0.832.
22. Association between adherence to the EAT-Lancet diet and risk of cancer and cardiovascular outcomes in the prospective NutriNet-Santé cohort. American Journal of Clinical Nutrition (2022). Observational — trust 0.825.
23. Trends in Planetary Health Diet Index for the United States (PHDI-US) Scores and Associations With Mortality Risk in the United States Between 1999 and 2020. Food Science & Nutrition (2026). Observational — trust 0.825.
24. Adherence to the Dietary Approaches to Stop Hypertension score and cardiovascular disease risk in Korean adults: a prospective cohort study. American Journal of Clinical Nutrition (2026). Observational — trust 0.802.
25. Association of Dietary Patterns and Genetic Risk With Cardiovascular Disease in UK Biobank Cancer Survivors. Journal of the American Heart Association (2026). Observational — trust 0.802.
26. Relationships of the Mediterranean dietary pattern with insulin resistance and diabetes incidence in the Multi-Ethnic Study of Atherosclerosis (MESA). British Journal of Nutrition (2012). Observational — trust 0.8.
27. Vegetarian and vegan diets and the risk of cardiovascular disease, ischemic heart disease and stroke: a systematic review and meta-analysis of prospective cohort studies. European Journal of Nutrition (2022). Systematic review — trust 0.792.
28. Alignment of Healthy Dietary Patterns and Environmental Sustainability: A Systematic Review. Advances in Nutrition (2016). Systematic review — trust 0.787.
29. Cause-specific and all-cause mortalities in vegetarian compared with those in nonvegetarian participants from the Adventist Health Study-2 cohort. American Journal of Clinical Nutrition (2024). Observational — trust 0.777.
30. Ultra-processed foods and cardiometabolic risk: from evidence to policy. npj Metabolic Health and Disease (2026). Review — trust 0.777.
31. The effects of low-carbohydrate diets on cardiovascular risk factors: A meta-analysis. PLOS ONE (2020). Systematic review — trust 0.772.
32. The Mediterranean diet and cardiovascular disease (PREDIMED re-analysis, CORDIOPREV, PREDIMED-Plus). Cardiovascular Research (2025). Review — trust 0.77.
33. Nutrient adequacy and environmental footprint of Mediterranean, pesco-, ovo-lacto-, and vegan menus: a modelling study. Frontiers in Nutrition (2025). Observational — trust 0.77.
34. Association between DASH diet adherence and mortality in non-diabetic adults with and without chronic kidney disease. Nutrition & Metabolism (2026). Observational — trust 0.77.
35. Vegetarian diets and cancer risk: pooled analysis of 1.8 million women and men in nine prospective studies on three continents. British Journal of Cancer (2026). Observational — trust 0.767.
36. Established dietary interventions and time-restricted eating for cardiovascular disease prevention. Cell Reports Medicine (2025). Review — trust 0.765.
37. Post hoc analysis of food costs associated with DASH diet, whole food plant-based diet, and typical baseline diet of individuals with insulin-treated type 2 diabetes. American Journal of Clinical Nutrition (2023). Observational — trust 0.762.
38. South Asia-specific adaptation of Mediterranean diet principles: a mixed-methods review. Frontiers in Nutrition (2025). Review — trust 0.76.
39. Consumption of ultra-processed foods and health status: a systematic review and meta-analysis. British Journal of Nutrition (2021). Systematic review — trust 0.755.
40. Effect of Carbohydrate-Restricted Diets and Intermittent Fasting on Obesity, Type 2 Diabetes Mellitus, and Hypertension Management: Consensus Statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hypertension. Diabetes & Metabolism Journal (2022). Guideline — trust 0.755.
41. Adherence to the combined Mediterranean-dietary approaches to stop hypertension diet is shaped by neighborhood socio-economics and food environments. Health and Place (2025). Observational — trust 0.752.
42. Position of the Academy of Nutrition and Dietetics: Vegetarian Diets. Journal of the Academy of Nutrition and Dietetics (2016). Guideline — trust 0.74.
43. Harnessing Metabolic Insights: A Framework for Dietary Patterns in Chronic Disease Prevention and Management. Advances in Nutrition (2026). Review — trust 0.748.

Supporting sources also surfaced: Causal Inference Framework Reveals Mediterranean Diet Superiority and Inflammatory Mediation Pathways in Mortality Prevention — Nine Dietary Patterns (Foods 2025, observational, trust 0.732); Plant-based diets for human health with implications for cardiometabolic health, gut microbiome, and nutritional adequacy (Frontiers in Nutrition 2026, review, trust 0.73); Neuroprotective Dietary Patterns and Longitudinal Changes in Cognitive Function in Older Adults (J Acad Nutr Diet 2024, observational, trust 0.742); Association between adherence to healthy dietary patterns and life expectancy in US adults (BMC Public Health 2025, observational, trust 0.742); The role of the MIND diet in prevention and treatment of Alzheimer's disease (Wiadomości Lekarskie 2026, review, trust 0.627); One diet, many indices: heterogeneity in measuring adherence to the EAT-Lancet planetary health diet (Int J Food Sci Nutr 2026, review, trust 0.725).

Note on gaps: several planned queries (Nordic diet as a standalone topic, intermittent fasting/time-restricted eating detail, and one dedicated Mediterranean-diet–mortality query) returned repeated timeouts/500 errors from the AllNutrition tool despite retry and were not force-completed; Nordic-diet and mortality-index findings that did surface incidentally (via the DASH blood-pressure and diet-quality-index queries) are cited above [9][23]. Intermittent fasting/time-restricted eating is addressed in depth in Module 27 and is intentionally only briefly cross-referenced here [36].